Opioid Treatment Program Certification
Overview
Certification is the process by which the SAMHSA/CSAT Division of Pharmacologic
Therapies (DPT) determines that an OTP is qualified to provide opioid treatment
under 42 CFR Part 8.
To obtain SAMHSA certification OTPs must successfully complete the
accreditation process and meet other requirements enumerated in 42 CFR Part
8. A program may apply to SAMHSA for provisional (initial) certification during
the time it is working towards accreditation with a SAMHSA-approved accrediting
body. Provisional certification is a temporary certification granted for up to one
year to a new OTP during which time it must become accredited.
Upon achieving accreditation a provisionally certified OTP may apply to SAMHSA for
renewal (full) certification. Once certified, programs must renew certification
at least every three years. For an overview of the OTP accreditation and certification
processes, view the Opioid Treatment Regulation page.
Programs applying for accreditation or certification must also comply with the applicable
statutes and regulations in their states. Contact information for State Opioid Treatment Authorities can be found on the
State Opioid Treatment Authority page.
Applying to SAMHSA for Initial or Renewal OTP Certification
Application to SAMHSA for provisional (initial) certification of a new OTP, or renewal
certification of an existing OTP, is made using Form SMA-162, Application for Certification
to Use Opioid Drugs in Treatment.
Follow the appropriate link below for information on:
Notifying SAMHSA of Program Changes
Existing OTPs must notify SAMHSA within 3 weeks of either of the following program
changes:
- Change of Program Sponsor
- Change of Medical Director
In addition, existing OTPs must apply to SAMHSA to receive approval for:
- Relocation
- Addition of new medical units (satellite clinics or mobile units)
Additional information about notifying SAMHSA of program changes is available on
the instruction page.
For More Information
For more information about OTP certification and opening a treatment program
In states beginning in A-FL, contact
- Mary Lou Ojeda
Public Health Advisor
Division of Pharmacologic Therapies
SAMHSA Center for Substance Abuse Treatment
mary.ojeda@samhsa.hhs.gov
Voice: 240.276.2894
Fax: 240.276.2710
In states beginning in GA-MI, contact
- Brandon Johnson
Public Health Advisor
Division of Pharmacologic Therapies
SAMHSA Center for Substance Abuse Treatment
brandon.johnson@samhsa.hhs.gov
Voice: 240.276.2889
Fax: 240.276.2889
In states beginning in MN-OH, contact
- Nichole Washington Smith
Public Health Advisor
Division of Pharmacologic Therapies
SAMHSA Center for Substance Abuse Treatment
nichole.washington@samhsa.hhs.gov
Voice: 240.276.2719
Fax: 240.276.2710
In states beginning in OK-WY, contact
- Steve Mason
Public Health Advisor
Division of Pharmacologic Therapies
SAMHSA Center for Substance Abuse Treatment
steve.mason@samhsa.hhs.gov
Voice: 240.276.2901
Fax: 240.276.2710
The mailing address for the above listed personnel is:
- Division of Pharmacologic Therapies
Center for Substance Abuse Treatment
SAMHSA
1 Choke Cherry Rd.
Rockville, MD 20857
(Overnight: 20850)
SMA-162 forms can completed in paper form and faxed or mailed
to SAMHSA and (where applicable) the State Opioid Treatment Authority.
![PDF File](https://webarchive.library.unt.edu/web/20130213220716im_/http://www.dpt.samhsa.gov/images/pdf4.gif) *PDF formatted files require that Adobe Acrobat Reader®
program.
Follow this link to download this FREE software now from Adobe.
|